| 488198 |
THE ONCOLOGIST |
Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib |
2019-11-01 |
10.1634/theoncologist.2019-0393 |
Principe Daniel R., Kamath Suneel D., Munshi Hidayatullah G., Mohindra Nisha A. |
| 488197 |
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY: JOURNAL OF GREATPOLAND CANCER CENTER IN POZNÁN AND POLISH SOCIETY OF RADIATION ONCOLOGY |
Feasibility study on the use of 230 MeV proton cyclotron in proton therapy centers as a spallation neutron source for BNCT. | Feasibility study on the use of 230 MeV proton cyclotron in proton therapy centers as a spallation neutron source for BNCT |
2019-11-01 |
10.1016/j.rpor.2019.10.005 |
Nobakht E., Fouladi N. |
| 488196 |
INDIAN HEART JOURNAL : OFFICIAL PUBLICATION OF THE CARDIOLOGICAL SOCIETY OF INDIA |
Comparative study of echocardiography and cardiac magnetic resonance imaging in non-compaction cardiomyopathy |
2019-11-01 |
10.1016/j.ihj.2019.11.154 |
Narayanan S. |
| 488195 |
BMJ OPEN |
Effects of e-aid cognitive behavioural therapy for insomnia (eCBTI) to prevent the transition from episodic insomnia to persistent insomnia: study protocol for a randomised controlled trial |
2019-11-01 |
10.1136/bmjopen-2019-033457 |
Yang Yuan, Luo Xian, Paudel Dhirendra, Zhang Jihui, Li Shirley Xin, Zhang Bin |
| 488194 |
BMJ OPEN |
Is neck circumference an appropriate tool to predict cardiovascular risk in clinical practice? A cross-sectional study in Chilean population |
2019-11-01 |
10.1136/bmjopen-2018-028305 |
Caro Patricia, Guerra Ximena, Canals Andrea, Weisstaub Gerardo, Sandaña Carlos |
| 488193 |
日本語文學 |
『源氏物語』의 四季 - 마보로시 권을 중심으로 - |
2019-11-01 |
10.21792/trijpn.2019..87.017 |
이애숙, |
| 488192 |
ENVIRONMENT INTERNATIONAL |
Prevalence and dissemination risk of antimicrobial-resistant Enterobacteriaceae from shared bikes in Beijing, China |
2019-11-01 |
10.1016/j.envint.2019.105119 |
Zou Zhi-Yu, Lei Lei, Chen Qi-Yan, Wang Yong-Qiang, Cai Chang, Li Wan-Qi, Zhang Zan, Shao Bing, Wang Yang |
| 488191 |
NEURO-ONCOLOGY |
ACTR-01. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP |
2019-11-01 |
10.1093/neuonc/noz175.046 |
Aoki Tomokazu, Arakawa Yoshiki, Ueba Tetsuya, Oda Masashi, Nishida Namiko, Akiyama Yukinori, Tsukahara Tetsuya, Iwasaki Koichi, Mikuni Nobuhiro, Miyamoto Susumu |
| 488190 |
NEURO-ONCOLOGY |
RTHP-34. IMPROVED SURVIVAL IN CNS LYMPHOMA WITH SALVAGE LOW-DOSE WHOLE-BRAIN RADIOTHERAPY WITH FOCAL BOOST AND CONCURRENT TEMOZOLOMIDE | RTHP-34. IMPROVED SURVIVAL IN CNS LYMPHOMA WITH SALVAGE LOW-DOSE WHOLE-BRAIN RADIOTHERAPY WITH FOCAL BOOST AND CONCURR |
2019-11-01 |
10.1093/neuonc/noz175.905 |
Selwa Katherine, Laucis Anna, Lawrence Theodore, Junck Larry, Cuneo Kyle, Kim Michelle, Wahl Daniel, Umemura Yoshie |
| 488189 |
NEURO-ONCOLOGY |
TMOD-16. MULTIFUNCTIONAL NANOPARTICLES USED FOR MAGNETIC RESONANCE/NIR FLUORESCENCE DUAL-MODAL IMAGING AND CHEMOTHERAPY OF GLIOMA | TMOD-16. MULTIFUNCTIONAL NANOPARTICLES USED FOR MAGNETIC RESONANCE/NIR FLUORESCENCE DUAL-MODAL IMAGING AND CHEMOTHERAPY OF |
2019-11-01 |
10.1093/neuonc/noz175.1115 |
Zhao Shiguang |
